Rchr
J-GLOBAL ID:200901095272865140   Update date: Apr. 10, 2024

Kumanogoh Atsushi

クマノゴウ アツシ | Kumanogoh Atsushi
Affiliation and department:
Job title: 教授
Research field  (2): Allergies and connective tissue disease ,  Immunology
Research keywords  (2): 免疫学 ,  Immunology
Research theme for competitive and other funds  (32):
  • 2023 - 2025 Development of CAR-T cell therapy for non-small cell lung cancer targeting the cancer-specific epitope associated with altered glycosylation in CD98hc protein
  • 2018 - 2023 神経・免疫・代謝におけるガイダンス因子の病的意義の解明とその制御
  • 2018 - 2019 神経・免疫・代謝におけるガイダンス因子の病的意義の解明とその制御
  • 2015 - 2018 Intracellular function of Sema4A in dendritic cells.
  • 2014 - 2017 Trials to treat progressive MS
Show all
Papers (445):
  • Hanako Yoshimura, Yoshito Takeda, Yuya Shirai, Makoto Yamamoto, Daisuke Nakatsubo, Saori Amiya, Takatoshi Enomoto, Reina Hara, Yuichi Adachi, Ryuya Edahiro, et al. Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology. The Journal of allergy and clinical immunology. 2024
  • Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Mayuko Izumi, Tomoki Kuge, Maiko Naito, Yumiko Mizuno, Yuta Yamaguchi, et al. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer. JCI insight. 2024. 9. 3
  • Mei Tomoto, Yohei Mineharu, Noriaki Sato, Yoshinori Tamada, Mari Nogami-Itoh, Masataka Kuroda, Jun Adachi, Yoshito Takeda, Kenji Mizuguchi, Atsushi Kumanogoh, et al. Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information. Scientific Reports. 2024. 14. 1
  • Shingo Satoh, Kotaro Miyake, Yuichi Adachi, Kentaro Masuhiro, Shinji Futami, Yujiro Naito, Takayuki Shiroyama, Shohei Koyama, Yuta Yamaguchi, Hachiro Konaka, et al. Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition. Biochemical and biophysical research communications. 2024. 696. 149511-149511
  • Kinnosuke Matsumoto, Takayuki Shiroyama, Motohiro Tamiya, Toshiyuki Minami, Yuhei Kinehara, Akihiro Tamiya, Yasuhiko Suga, Tomoki Kuge, Masahide Mori, Hidekazu Suzuki, et al. Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study. Cancer immunology, immunotherapy : CII. 2024. 73. 1. 4-4
more...
MISC (604):
  • 行木紳一郎, 山口勇太, 加藤保宏, 村上輝明, 吉峰由子, 網屋沙織, 森田貴義, 沖田康孝, 川崎貴裕, 藤本潤, et al. 自己免疫性疾患患者におけるSARS-CoV-2mRNAワクチン効果の持続性に関する検討. 日本臨床免疫学会総会プログラム・抄録集. 2023. 51st
  • 松本錦之介, 白山敬之, 田宮基裕, 田宮朗裕, 飛田哲志, 柳瀬隆文, 菅泰彦, 森雅秀, 灘波良信, 鉄本訓史, et al. 傾向スコアマッチング法を用いたニボルマブ+イピリムマブ単独vs化学療法併用の比較検討. 日本肺癌学会学術集会号. 2023. 64th (CD-ROM)
  • 甲田亨, 奥野龍禎, 木下允, 望月秀樹, 宮本勝一, 新野正明, 清水優子, 山本真守, 熊ノ郷淳, 中辻裕司. 多発性硬化症治療における免疫セマホリンSema4AとDMD反応性の関連の検討. 日本神経学会学術大会プログラム・抄録集. 2023. 64th
  • 甲田亨, 奥野龍禎, 木下允, 望月秀樹, 宮本勝一, 新野正明, 清水優子, 山本真守, 熊ノ郷淳, 中辻裕司. 多発性硬化症治療における免疫セマホリンSema4AとDMD治療反応性の検討. Neuroimmunology. 2023. 28. 1
  • 山本悠司, 平田陽彦, 白山敬之, 久下朋輝, 松本錦之介, 米田翠, 山本真, 内藤祐二朗, 菅泰彦, 福島清春, et al. Evaluation of ventilation and diffusing capacity using oscillometry in patients with idiopathic pulmonary fibrosis combined with emphysema. 日本呼吸器学会誌(Web). 2023. 12
more...
Education (4):
  • - 1997 Osaka University
  • - 1997 Osaka University Graduate School, Division of Medicine
  • - 1991 Osaka University Faculty of Medicine Medical School
  • - 1991 Osaka University Faculty of Medicine
Professional career (1):
  • (BLANK)
Association Membership(s) (7):
日本内科学会 ,  日本免疫学会 ,  日本骨免疫学会 ,  日本炎症・再生学会 ,  日本臨床免疫学会 ,  American Society for Clinical Investigation ,  日本リウマチ学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page